The year in cardiovascular medicine 2021: imaging.
Eur Heart J
; 43(13): 1288-1295, 2022 03 31.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1730673
ABSTRACT
This article reviews the most relevant literature published in 2021 on the role of cardiovascular imaging in cardiovascular medicine. Coronavirus disease 2019 (COVID-19) continued to impact the healthcare landscape, resulting in reduced access to hospital-based cardiovascular care including reduced routine diagnostic cardiovascular testing. However, imaging has also facilitated the understanding of the presence and extent of myocardial damage caused by the coronavirus infection. What has dominated the imaging literature beyond the pandemic are novel data on valvular heart disease, the increasing use of artificial intelligence (AI) applied to imaging, and the use of advanced imaging modalities in both ischaemic heart disease and cardiac amyloidosis.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Isquemia Miocárdica
/
COVID-19
/
Amiloidosis
Tipo de estudio:
Estudios diagnósticos
Límite:
Humanos
Idioma:
Inglés
Revista:
Eur Heart J
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Eurheartj
Similares
MEDLINE
...
LILACS
LIS